Lombard Odier Asset Management USA Corp grew its position in shares of Quotient Ltd (NASDAQ:QTNT) by 4.0% in the first quarter, HoldingsChannel reports. The firm owned 260,000 shares of the company’s stock after purchasing an additional 10,000 shares during the period. Lombard Odier Asset Management USA Corp’s holdings in Quotient were worth $2,343,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in QTNT. SlateStone Wealth LLC purchased a new position in shares of Quotient during the 4th quarter valued at $91,000. Niemann Capital Management Inc. purchased a new position in shares of Quotient during the 1st quarter valued at $101,000. Resources Investment Advisors Inc. purchased a new position in shares of Quotient during the 1st quarter valued at $105,000. Rehmann Capital Advisory Group purchased a new position in shares of Quotient during the 1st quarter valued at $154,000. Finally, Westfield Capital Management Co. LP purchased a new position in shares of Quotient during the 1st quarter valued at $217,000. Hedge funds and other institutional investors own 63.91% of the company’s stock.
In related news, President Edward Farrell sold 22,500 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $8.67, for a total value of $195,075.00. Following the completion of the transaction, the president now directly owns 2,133 shares in the company, valued at $18,493.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Jeremy Stackawitz sold 21,495 shares of the company’s stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $9.93, for a total transaction of $213,445.35. Following the completion of the transaction, the president now owns 131,939 shares of the company’s stock, valued at $1,310,154.27. The disclosure for this sale can be found here. 17.40% of the stock is currently owned by insiders.
A number of research analysts have recently commented on the stock. BidaskClub lowered shares of Quotient from a “hold” rating to a “sell” rating in a research report on Tuesday, June 11th. ValuEngine lowered shares of Quotient from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 3rd. Finally, Zacks Investment Research upgraded shares of Quotient from a “sell” rating to a “hold” rating in a research report on Wednesday, May 8th.
Shares of NASDAQ:QTNT opened at $8.57 on Monday. Quotient Ltd has a 52-week low of $5.52 and a 52-week high of $11.15. The firm has a market capitalization of $567.16 million, a P/E ratio of -4.46 and a beta of 1.01. The company has a quick ratio of 3.98, a current ratio of 4.59 and a debt-to-equity ratio of 72.27.
Quotient (NASDAQ:QTNT) last announced its earnings results on Tuesday, May 28th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.03. The company had revenue of $8.28 million during the quarter, compared to analysts’ expectations of $7.30 million. Sell-side analysts predict that Quotient Ltd will post -1.59 EPS for the current year.
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.
Read More: Forex
Want to see what other hedge funds are holding QTNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quotient Ltd (NASDAQ:QTNT).
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.